Micropocket-Based Differentiation System to Streamline and Scale Stem Cell-Derived Pancreatic Islet Production

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cell Therapy

Background:

• Stem-cell-derived islets (SC-islets) are a promising alternative to cadaveric islets for type 1 diabetes treatment.
• Controlling SC-islet aggregate size is crucial for reproducibility and therapeutic efficacy.
• Current methods face challenges in scalability and maintaining consistent aggregate dimensions due to fusion and oxygen limitations.

Purpose of the Study:

• To develop and validate a scalable culture system for producing uniform SC-islets.
• To address the limitations of conventional methods in controlling aggregate size during differentiation.
• To enhance the potential for therapeutic applications of SC-islets.

Main Methods:

• Fabrication of a micropocket hydrogel platform with a lip-and-funnel geometry to capture and protect cellular aggregates.
• Aggregation and differentiation of pancreatic progenitor cells into SC-islets over 23 days within the micropockets.
• Assessment of aggregate size, shear stress protection, and aggregate retention during media exchange.

Main Results:

• The micropocket platform maintained consistent SC-islet aggregate sizes (136 μm ± 31 μm SD), comparable to human islets.
• Aggregates in suspension culture exhibited uncontrolled growth (114 μm ± 8 μm SD to 275 μm ± 62 μm SD) due to fusion.
• The micropockets reduced shear stress by approximately 50× and prevented aggregate loss during media exchanges, demonstrating scalability.

Conclusions:

• The micropocket hydrogel system offers a robust and scalable method for producing uniform SC-islets.
• This approach overcomes key challenges in SC-islet production, including aggregate fusion and microenvironmental control.
• The technology holds significant potential for the therapeutic manufacturing of stem-cell-derived islets for type 1 diabetes treatment.